Biopharmaceutical company focused on small molecule therapeutics for the treatment of cardiovascular disorders.
- Year invested 1999
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website myogen.com
- Company Status IPO/Public (by Gilead Sciences)